Title :
Notice of Retraction
Does R&D investment promote firms´ performance? Evidence from the pharmaceutical and biological products listed firms
Author :
Zhu Zhaohui ; Chai Xiaokang
Author_Institution :
Sch. of Accounting, Zhejiang Gongshang Univ., Hangzhou, China
Abstract :
Notice of Retraction
After careful and considered review of the content of this paper by a duly constituted expert committee, this paper has been found to be in violation of IEEE´s Publication Principles.
We hereby retract the content of this paper. Reasonable effort should be made to remove all past references to this paper.
The presenting author of this paper has the option to appeal this decision by contacting TPII@ieee.org.
Technological innovation by Research and Development (R&D) is at the core of business strategy for firms to compete in the competitive market. This paper tests the correlation between firms R&D investment intensity and the current year / one-year lagged performance of Chinese pharmaceutical and biological products Listed firms, and suggests that there´s weak significant correlation between R&D intensity and the current year´s performance, and there´s more stronger significant correlation with the following year´s performance.
Keywords :
biotechnology; investment; pharmaceutical industry; research and development; strategic planning; R and D investment intensity; biological products listed firms; business strategy; firm performance promotion; pharmaceutical products listed firms; research and development; Biology; Companies; Correlation; Investments; Pharmaceuticals; Technological innovation; IT Firms; R&D; ROA;
Conference_Titel :
Product Innovation Management (ICPIM), 2011 6th International Conference on
Conference_Location :
Wuhan
Print_ISBN :
978-1-4577-0359-1
DOI :
10.1109/ICPIM.2011.5983599
